Introduction to the Network
The Lung Cancer Policy Network was established in 2021 as an initiative of the Lung Ambition Alliance. It is a global network of multidisciplinary experts from across the lung cancer community, which includes clinicians, researchers, patient organisations and industry partners.
The Network aims to improve lung cancer survival worldwide. We do this by engaging policymakers – sharing research, reports and recommendations that highlight opportunities to diagnose and treat lung cancer earlier. We hope to make lung cancer an international policy priority, and by doing so, improve quality of life for people diagnosed with lung cancer and to reduce the number of deaths caused by the condition.
Initially, the Network will focus on collating and sharing knowledge about lung cancer screening from experts around the world. We will translate this knowledge into evidence to encourage policymakers to champion the adoption of lung cancer screening. We also aim to help equip those delivering lung cancer screening programmes by creating a platform that enables experts to share best practice based on their experience of implementation.
The Network currently has almost 50 members and will develop additional activities that build on this lung cancer screening work in the coming years.
The Lung Ambition Alliance
The Lung Ambition Alliance (LAA) initiated the formation of the Network. The LAA is a global coalition of organisations spanning the commercial and non-profit sectors, united by a common goal of doubling the five-year survival rate for lung cancer and an ultimate ambition to eliminate lung cancer as a cause of death.
The International Association for the Study of Lung Cancer (IASLC), Global Lung Cancer Coalition (GLCC), AstraZeneca and Guardant Health are the founding partners of the LAA, representing patient organisations, scientific and medical societies, and industry.
The Network contributes to the LAA’s ambition of doubling lung cancer survival by 2025, as well as encouraging early detection of lung cancer through screening.
As a first objective, the Network is focusing on the huge opportunity offered by targeted lung cancer screening. We are advocating for the wide-spread implementation of organised lung cancer screening programmes.
The Network’s objectives are to:
- provide consensus-driven insights from experts on how to implement lung cancer screening effectively
- create awareness around the need for lung cancer screening, and the momentum to drive its implementation
- facilitate learning on the most effective ways to screen for lung cancer.
Core activities of the Network
The Network will engage with policymakers to make the case that lung cancer should be a key part of the policy agenda.
As a Network we are focusing our core activities on producing publications and resources, including an interactive map of lung cancer screening implementation that will:
- provide a global overview of, and expert perspective on, the evidence base for lung cancer screening implementation
- share the expert experience of those currently engaged in the implementation of targeted LDCT for lung cancer screening
- support advocates calling for policy change at a national level to implement lung cancer screening.
Further workstreams will be developed in the future with a focus on other topics that will contribute to improving lung cancer survival. Network members will be key to shaping the focus of these future workstreams.
Network member organisations
- GO2 Foundation for Lung Cancer
- Global Lung Cancer Coalition (GLCC)
- Institute for DiagNostic Accuracy (iDNA)
- International Association for the Study of Lung Cancer (IASLC)
- Screening and Early Detection Committee
- International Early Lung Cancer Action Program (I-ELCAP)
- Lung Cancer Europe (LuCE)
- Prevent Cancer Foundation
- Roy Castle Lung Cancer Foundation
- Vision Zero Cancer
- Women Against Lung Cancer in Europe (WALCE)